ANTIPROLIFERATIVE AND SYNERGISTIC EFFECT OF INTERFERON ALPHA-2A, RETINOIDS AND THEIR ASSOCIATION IN ESTABLISHED HUMAN CANCER CELL-LINES

被引:40
|
作者
TOMA, S
MONTEGHIRFO, S
TASSO, P
NICOLO, G
SPADINI, N
PALUMBO, R
MOLINA, F
机构
[1] UNIV GENOA,INST CLIN & EXPTL ONCOL,GENOA,ITALY
[2] UNIV GENOA,INST CLIN DENT,GENOA,ITALY
[3] ADV BIOTECHNOL CTR,GENOA,ITALY
关键词
ALPHA-INTERFERON; 2A; RETINOIDS; SYNERGISTIC EFFECT;
D O I
10.1016/0304-3835(94)90014-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effect of 13-cis-retinoic acid (cRA) and all-trans-retinoic acid (tRA) used alone or in combination with interferon alpha-2a (alpha-IFN 2a) was tested on three established human cell lines: KB (epidermoid carcinoma of the oral cavity), SCC-25 (tongue squamous cell carcinoma) and MCF-7 (mammary carcinoma). Both retinoids significantly decreased cell proliferation (growth curves) and colony forming efficiency (CFE) in all cell lines, in a dose-dependent way (at a concentration ranging from 10(-5) to 10(-9) M) and differing from line to line, following the pattern: MCF-7 > SCC-25 > KB. Retinoids at any concentration (already at 10(-7) M) combined with alpha-IFN 2a (ranging from 100 to 500 IU/ml) were more effective in inhibiting cell proliferation than each of the two compounds alone. This was particularly evident with SCC-25 cells. Concerning MCF-7 cells, on the contrary, the effects produced by the association suggested a possible additive more than synergistic amplification of growth inhibition.
引用
收藏
页码:209 / 216
页数:8
相关论文
共 50 条
  • [1] MODULATION OF CISPLATIN SENSITIVITY AND ACCUMULATION BY INTERFERON ALPHA-2A IN HUMAN SQUAMOUS CARCINOMA CELL-LINES
    GUPTA, V
    JANI, JP
    EMERSON, EO
    XU, BH
    SCALAMOGNA, D
    XIA, H
    KATOH, A
    ZAREN, HA
    SINGH, SV
    INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (03) : 419 - 422
  • [2] ANTIPROLIFERATIVE ACTIVITY OF RETINOIDS, INTERFERON ALPHA AND THEIR COMBINATION IN 5 HUMAN TRANSFORMED-CELL LINES
    FREY, JR
    PECK, R
    BOLLAG, W
    CANCER LETTERS, 1991, 57 (03) : 223 - 227
  • [3] SYNERGISTIC ANTIPROLIFERATIVE ACTIVITY OF SURAMIN AND INTERFERON-ALPHA-2A AGAINST HUMAN COLORECTAL ADENOCARCINOMA CELL-LINES - IN-VITRO STUDIES
    FALCONE, A
    DANESI, R
    ZACCARO, L
    PIERACCI, D
    PFANNER, E
    CIANCI, C
    ANDREUCCETTI, M
    MALVALDI, G
    DELTACCA, M
    CONTE, PF
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (04) : 516 - 520
  • [4] ANTIPROLIFERATIVE ACTIVITY OF INTERFERON-ALPHA ON HUMAN SQUAMOUS CARCINOMA OF TONGUE CELL-LINES
    KING, WWK
    LAM, PK
    LI, AKC
    CANCER LETTERS, 1994, 85 (01) : 55 - 58
  • [5] THE ANTIPROLIFERATIVE EFFECTS OF SYNTHETIC RETINOIDS AND AROTINOIDS ON HUMAN OVARIAN AND BREAST-CANCER CELL-LINES
    TAYLOR, CM
    BLANCHARD, B
    WETHERALL, NT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 360 - 360
  • [6] HUMAN INTERFERON (IN) AND ALPHA-DIFLUOROMETHYLORNITHINE (DFMO) HAVE SYNERGISTIC ANTIPROLIFERATIVE ACTIVITY AGAINST HUMAN-TUMOR CELL-LINES INVITRO
    KOVACH, JS
    SVINGEN, PA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 326 - 326
  • [7] SYNERGISTIC ANTIPROLIFERATIVE EFFECTS OF HUMAN RECOMBINANT ALPHA-54-INTERFERON OR BETA-SER-INTERFERON WITH GAMMA-INTERFERON ON HUMAN CELL-LINES OF VARIOUS HISTOGENESIS
    SCHILLER, JH
    GROVEMAN, DS
    SCHMID, SM
    WILLSON, JKV
    CUMMINGS, KB
    BORDEN, EC
    CANCER RESEARCH, 1986, 46 (02) : 483 - 488
  • [8] ANTIPROLIFERATIVE EFFECTS OF ISOFLAVONES ON HUMAN CANCER CELL-LINES ESTABLISHED FROM THE GASTROINTESTINAL-TRACT
    YANAGIHARA, K
    ITO, A
    TOGE, T
    NUMOTO, M
    CANCER RESEARCH, 1993, 53 (23) : 5815 - 5821
  • [9] THE ANTIPROLIFERATIVE EFFECT OF CYCLOSPORINE ON HEMATOPOIETIC AND LYMPHOBLASTOID CELL-LINES - COMMON MECHANISTIC ELEMENTS WITH INTERFERON-ALPHA
    YONISHROUACH, E
    KIMCHI, A
    RUBINSTEIN, M
    TRANSPLANTATION, 1991, 51 (06) : 1276 - 1282
  • [10] ANTIPROLIFERATIVE ACTION OF RECOMBINANT ALPHA-INTERFERON AND GAMMA-INTERFERON ON 2 NEW HUMAN RENAL-CARCINOMA (RC) CELL-LINES
    VOGELZANG, NJ
    PADDON, KJ
    BROWNSTEIN, BH
    CLINICAL RESEARCH, 1985, 33 (04): : A855 - A855